Abdominal surgery is a common procedure that is performed to treat a variety of conditions. While it is generally considered a safe and effective treatment, there are potential risks and complications associated with it, including rectus sheath hematoma (RSH). RSH is a rare but serious complication of abdominal surgery that can lead to severe bleeding and even death. This article will discuss the danger of rectus sheath hematoma, its causes, risk factors, diagnosis, and treatment.
Rectus sheath hematoma is a rare but serious complication of abdominal surgery. It is a collection of blood that accumulates between the rectus abdominis muscle and the rectus sheath, which is a thin layer of tissue that wraps around the rectus abdominis muscle. RSH can occur after any abdominal surgery, including laparoscopic surgery, and is usually caused by trauma to the rectus sheath during the surgery.
There are several risk factors for developing RSH after abdominal surgery. These include: • Advanced age: Elderly patients are at higher risk for developing RSH. • Coagulopathy: Patients with a bleeding disorder are at an increased risk of developing RSH. • Use of anticoagulants: Patients who are taking anticoagulant medications such as warfarin are at an increased risk of developing RSH. • Use of vasopressors: Patients who are taking vasopressors such as epinephrine are at an increased risk of developing RSH. • Previous abdominal surgery: Patients who have had previous abdominal surgery are at an increased risk of developing RSH.
The diagnosis of RSH is usually made based on the patient’s symptoms and physical examination. Common symptoms of RSH include abdominal pain, tenderness, and distention. On physical examination, the abdomen may be distended and tender to palpation. Imaging studies, such as ultrasound or computed tomography (CT) scan, may be used to confirm the diagnosis and assess the extent of the hematoma.
Treatment for RSH depends on the severity of the hematoma. Mild cases may be managed with conservative measures such as bed rest, pain medications, and supportive care. More severe cases may require surgical intervention. Surgical treatment may include drainage of the hematoma, debridement of necrotic tissue, and repair of the rectus sheath.
Rectus sheath hematoma is a rare but serious complication of abdominal surgery. It is important for doctors to be aware of the risk factors for RSH, as well as the signs and symptoms, so that they can diagnose and treat it promptly. Treatment for RSH depends on the severity of the hematoma, but may include conservative measures or surgical intervention.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation